Navigation Links
Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
Date:8/9/2011

pain and sweating.

"Lilly is committed to providing information regarding our therapies to help healthcare professionals and their patients engage in more informed discussions about available treatment options for postmenopausal osteoporosis," said co-author John Krege, M.D., medical fellow, Eli Lilly and Company.

About the Review"Long-term Raloxifene for Postmenopausal Osteoporosis" is a literature review of available information concerning EVISTA use for greater than three years for the treatment of postmenopausal osteoporosis and invasive breast cancer risk reduction in postmenopausal women with osteoporosis. Two reviewed studies were the Multiple Outcomes of Raloxifene Evaluation (MORE) trial and the Continued Outcomes of Raloxifene Evaluation (CORE) trial. The review includes summaries of previously published information, as well as a number of previously unpublished observations from analyses of the clinical study databases. In addition, new data from three patients who underwent iliac crest bone biopsies after eight years of EVISTA therapy were reported.

About EVISTA® (raloxifene HCl tablets)EVISTA is an estrogen agonist/antagonist, commonly referred to as a selective estrogen receptor modulator (SERM), which appears to act like estrogen in bone and to block the effects of estrogen in some tissues. It is an osteoporosis therapy for postmenopausal women that also reduces the risk of invasive breast cancer in postmenopausal women with osteoporosis.

EVISTA is approved by the U.S. Food and Drug Administration (FDA) for the treatment and prevention of osteoporosis in postmenopausal women.  EVISTA is also indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. There are Important Limitations of Use for breast cancer risk reduction:

  • There are no data available regarding the effect of EVISTA on invasive breast cancer incidence in women with inherited mutations
    '/>"/>

    • SOURCE Eli Lilly and Company
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
    2. Eli Lilly India and Lupin Announce Strategic Collaboration to Help Fight the Battle Against Diabetes
    3. Lilly Launches Physician Payment Registry
    4. Lilly Reports Second-Quarter 2011 Results
    5. Lilly Presents Follow-Up Data on Semagacestat to Assist Future Alzheimers Disease Research
    6. Lilly and Argonne National Laboratory Announce $2 Million Upgrade to Lillys Beamline Capabilities
    7. Lilly Donation to Patient Advocate Foundation Expands Services and Access for Patients With Most Common Form of Lung Cancer
    8. Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
    9. Lilly CEO Calls for Improved Dialogue in Germany Between Industry and the Government and Health Care System
    10. Lilly Quality Leader Walsh Appointed to Companys Executive Committee
    11. Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2013)... RIVER EDGE, N.J. , May 23, 2013 /PRNewswire/ ... ), a commercial stage medical device company that develops ... the successful completion of its rights offering.  In addition, ... company,s March 2011 warrants expired on May 17, 2013. ... proceeds of $3.0 million from the rights offering.   A ...
    (Date:5/23/2013)... -- A recently published clinical study conducted at TOPS Comprehensive ... demonstrates that 3D mammography (breast tomosynthesis) significantly reduces unnecessary ... The study, "Implementation of Breast Tomosynthesis in a Routine ... Stephen L. Rose , MD, and published ... of Roentgenology (AJR). The AJR is the scientific ...
    (Date:5/23/2013)... , May 23, 2013 More than half ... not benefit from chemotherapy and still have excellent outcomes. ... of one of the largest sources of online consumer ... and interactive Facebook page provide recently diagnosed women with ... safely avoid chemotherapy. "We anticipate these innovative ...
    Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3
    ... Telik, Inc.,(Nasdaq: TELK ) announced that preclinical ... kinase inhibitors will be presented at the,AACR-NCI-EORTC Conference ... The presentation, "In Vitro and Vivo Anticancer Activities,of ... # C206) will be,on Thursday, October 25, 2007, ...
    ... technology developed by researchers at Reproductive Medicine Associates, of New ... ... Meeting, WASHINGTON and MORRISTOWN, N.J., Oct. 18 Researchers ... for research at the American Society for Reproductive Medicine (ASRM),for ...
    Cached Medicine Technology:Researchers Develop New Procedure to Screen All 46 Human Chromosomes to Identify Abnormalities in Embryos 2Researchers Develop New Procedure to Screen All 46 Human Chromosomes to Identify Abnormalities in Embryos 3
    (Date:5/23/2013)... The vast majority of Americans believe it’s possible ... level of physical activity, the healthfulness of their diet ... that control. Those are among the findings of ... & Health Survey. , According to the Survey, 90 ... great deal of control” or “complete control” over their ...
    (Date:5/23/2013)... 2013 Click here to read the ... are increasingly seeing their success develop through merger ... according to new research carried out by MaRS ... company has compiled its research into a series of ... the research have shown the general trend that the ...
    (Date:5/23/2013)... 23, 2013 Jeanne Ettelson, president of ... its popular and only free OCD support group in ... resource for OCD sufferers, the group is lead by ... disorders. This allows group participants to learn accurate ... Response Prevention. , “Participants in Beyond OCD’s support ...
    (Date:5/23/2013)... Cheap Concert Tickets announces that Paul McCartney ... throughout North America. This well known ticket website has ... to help McCartney fans see Sir Paul live in concert. ... she is also offering the customer appreciation code SAVE for ... boomer, she is also a huge McCartney fan and plans ...
    (Date:5/23/2013)... News) -- Schools should ensure that kids get ... day to support their health and boost performance ... Although previous studies show 60 minutes of ... development, it,s estimated that only about 50 percent ... according to the report from the Institute of ...
    Breaking Medicine News(10 mins):Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 2Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 3Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 4Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 4Health News:Beyond OCD Support Group Marks Fifth Anniversary 2Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:U.S. School Kids Should Get Hour of Exercise Daily: Report 2
    ... , , Agency says ... SILVER SPRING, Md. , Feb. 5 ... Bayesian statistical methods in the design and analysis of medical ... more efficient patient studies. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , ...
    ... erosive esophagitis and is the pre-malignant condition for adenocarcinoma ... City University School of Medicine hypothesized that some macroscopic ... a subgroup with a high risk for the development ... January 28, 2010 in the World Journal of ...
    ... Whitewater Courses ... and challenge participants with hard-to-hear truths about the responsibilities of developers who promote atop ... recreation, designers, engineers and river scientist will take place May 24-27, 2010 in Salida, CO. ... (PRWEB) March 3, 2010 ...
    ... stable longer , THURSDAY, Feb. 4 (HealthDay News) -- New ... diabetes could benefit by using an artificial pancreas device to ... sleep and help them control their disease. , The findings, ... Lancet , examined use of an artificial pancreas by people ...
    ... Lean Learning ... need for small-scale reference cards that communicate core Lean concepts in a visually engaging way. ... (PRWEB) February 5, 2010 ... of twelve illustrated cards that teach core Lean concepts with a light and humorous touch. ...
    ... ... Charlemagne Educational Marketing, LLC launched the release of Swiggs™, the very first live action ... , ... February 5, 2010 -- On February 4, 2010, Charlemagne Educational Marketing, LLC launched the ...
    Cached Medicine News:Health News:FDA Issues Guidance to Help Streamline Medical Device Clinical Trials 2Health News:FDA Issues Guidance to Help Streamline Medical Device Clinical Trials 3Health News:Hard Green Truths - Keynotes Suggest New Value Propositions for River Park Leaders 2Health News:Artificial Pancreas Helps Type 1 Diabetics During Sleep 2Health News:Lean Thinking Pocket Cards Teach Core Concepts -- and Inspire Action 2Health News:First Animated Instructional Oral Sex Video Reaches Mainstream America, Despite the Touchy and Controversial Subject Matter 2
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: